

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76798169 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63421688 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.63421688 |
| 4 | positive regulation of granulocyte differentiation (GO:0030854) | 3.58142672 |
| 5 | negative regulation of granulocyte differentiation (GO:0030853) | 3.54578019 |
| 6 | tolerance induction (GO:0002507) | 3.49844279 |
| 7 | positive regulation of histone deacetylation (GO:0031065) | 3.40979711 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40151592 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.40151592 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40151592 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40151592 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40151592 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.40151592 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37175485 |
| 15 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.33230374 |
| 16 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.23459776 |
| 17 | regulation of B cell apoptotic process (GO:0002902) | 3.22069513 |
| 18 | auditory receptor cell differentiation (GO:0042491) | 3.20392398 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16372981 |
| 20 | negative regulation of bone resorption (GO:0045779) | 3.15571142 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.15309092 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14634101 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.11762320 |
| 24 | definitive hemopoiesis (GO:0060216) | 3.10949716 |
| 25 | keratinocyte development (GO:0003334) | 3.09423293 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08600158 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.04864010 |
| 28 | cellular extravasation (GO:0045123) | 3.02020421 |
| 29 | negative regulation of phagocytosis (GO:0050765) | 2.98860003 |
| 30 | germ cell migration (GO:0008354) | 2.98124069 |
| 31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94091274 |
| 32 | positive regulation of glycolytic process (GO:0045821) | 2.93958193 |
| 33 | mannose metabolic process (GO:0006013) | 2.90242348 |
| 34 | cellular response to antibiotic (GO:0071236) | 2.89802325 |
| 35 | hepatocyte apoptotic process (GO:0097284) | 2.87672371 |
| 36 | negative regulation of interleukin-8 production (GO:0032717) | 2.86567046 |
| 37 | negative regulation of bone remodeling (GO:0046851) | 2.85378805 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85259647 |
| 39 | neutrophil activation (GO:0042119) | 2.84454692 |
| 40 | gland morphogenesis (GO:0022612) | 2.82429385 |
| 41 | Rap protein signal transduction (GO:0032486) | 2.82072020 |
| 42 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.79919537 |
| 43 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.79265831 |
| 44 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.79265831 |
| 45 | growth hormone receptor signaling pathway (GO:0060396) | 2.78611235 |
| 46 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.77324387 |
| 47 | ER overload response (GO:0006983) | 2.75650228 |
| 48 | leukocyte aggregation (GO:0070486) | 2.75520277 |
| 49 | negative regulation of cell killing (GO:0031342) | 2.74052187 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74052187 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 2.72220924 |
| 52 | endocrine pancreas development (GO:0031018) | 2.69500492 |
| 53 | sequestering of metal ion (GO:0051238) | 2.66801301 |
| 54 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.66768547 |
| 55 | positive regulation of macrophage differentiation (GO:0045651) | 2.64975479 |
| 56 | negative regulation of acute inflammatory response (GO:0002674) | 2.64112096 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 2.61791438 |
| 58 | pinocytosis (GO:0006907) | 2.61275093 |
| 59 | skin morphogenesis (GO:0043589) | 2.60188791 |
| 60 | granulocyte activation (GO:0036230) | 2.59678344 |
| 61 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.58918287 |
| 62 | interkinetic nuclear migration (GO:0022027) | 2.58543053 |
| 63 | regulation of B cell differentiation (GO:0045577) | 2.58429115 |
| 64 | negative regulation of humoral immune response (GO:0002921) | 2.57739467 |
| 65 | neutrophil mediated immunity (GO:0002446) | 2.55775010 |
| 66 | negative regulation of B cell proliferation (GO:0030889) | 2.53981154 |
| 67 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.53313496 |
| 68 | photoreceptor cell differentiation (GO:0046530) | 2.52839347 |
| 69 | eye photoreceptor cell differentiation (GO:0001754) | 2.52839347 |
| 70 | response to xenobiotic stimulus (GO:0009410) | 2.52834161 |
| 71 | negative regulation of fatty acid transport (GO:2000192) | 2.52664073 |
| 72 | negative regulation of protein oligomerization (GO:0032460) | 2.51919668 |
| 73 | histone H3-K36 demethylation (GO:0070544) | 2.51349539 |
| 74 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.50747095 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49943495 |
| 76 | parental behavior (GO:0060746) | 2.49325081 |
| 77 | response to laminar fluid shear stress (GO:0034616) | 2.48953830 |
| 78 | fucose catabolic process (GO:0019317) | 2.48747806 |
| 79 | L-fucose metabolic process (GO:0042354) | 2.48747806 |
| 80 | L-fucose catabolic process (GO:0042355) | 2.48747806 |
| 81 | positive T cell selection (GO:0043368) | 2.47917608 |
| 82 | cellular response to ethanol (GO:0071361) | 2.46931008 |
| 83 | regulation of hexokinase activity (GO:1903299) | 2.45576271 |
| 84 | regulation of glucokinase activity (GO:0033131) | 2.45576271 |
| 85 | negative regulation of complement activation (GO:0045916) | 2.45408337 |
| 86 | regulation of germinal center formation (GO:0002634) | 2.42712643 |
| 87 | negative regulation of tissue remodeling (GO:0034104) | 2.42579785 |
| 88 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.41733833 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.40462655 |
| 90 | megakaryocyte development (GO:0035855) | 2.39706409 |
| 91 | cellular response to toxic substance (GO:0097237) | 2.39586396 |
| 92 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.38758462 |
| 93 | heparin biosynthetic process (GO:0030210) | 2.38667518 |
| 94 | heparin metabolic process (GO:0030202) | 2.38667518 |
| 95 | histone H3-K4 trimethylation (GO:0080182) | 2.38576610 |
| 96 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.38488021 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38043678 |
| 98 | cellular response to growth hormone stimulus (GO:0071378) | 2.37572407 |
| 99 | regulation of mRNA catabolic process (GO:0061013) | 2.37151844 |
| 100 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35700669 |
| 101 | response to peptidoglycan (GO:0032494) | 2.34042904 |
| 102 | positive regulation of mRNA catabolic process (GO:0061014) | 2.33796610 |
| 103 | positive regulation of Rap GTPase activity (GO:0032854) | 2.33742962 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.33427134 |
| 105 | B cell homeostasis (GO:0001782) | 2.32908739 |
| 106 | positive regulation of protein deacetylation (GO:0090312) | 2.32655801 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 2.32417880 |
| 108 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.32366923 |
| 109 | regulation of erythrocyte differentiation (GO:0045646) | 2.31914639 |
| 110 | negative thymic T cell selection (GO:0045060) | 2.29426560 |
| 111 | B cell receptor signaling pathway (GO:0050853) | 2.29184744 |
| 112 | response to fungus (GO:0009620) | 2.28535743 |
| 113 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.27806090 |
| 114 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.27806090 |
| 115 | apoptotic cell clearance (GO:0043277) | 2.25667481 |
| 116 | microglial cell activation (GO:0001774) | 2.25590450 |
| 117 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.24558672 |
| 118 | toxin transport (GO:1901998) | 2.24462866 |
| 119 | interferon-gamma production (GO:0032609) | 2.24170862 |
| 120 | respiratory burst (GO:0045730) | 2.23512687 |
| 121 | histone demethylation (GO:0016577) | 2.23499477 |
| 122 | protein K11-linked deubiquitination (GO:0035871) | 2.22143869 |
| 123 | regulation of granulocyte differentiation (GO:0030852) | 2.21718397 |
| 124 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.20712791 |
| 125 | thymic T cell selection (GO:0045061) | 2.20105574 |
| 126 | negative regulation of protein autophosphorylation (GO:0031953) | 2.19567948 |
| 127 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.19538953 |
| 128 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.18206616 |
| 129 | type B pancreatic cell development (GO:0003323) | 2.17193123 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17126821 |
| 131 | cellular response to exogenous dsRNA (GO:0071360) | 2.16468328 |
| 132 | positive regulation of chemokine secretion (GO:0090197) | 2.16138373 |
| 133 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.15972191 |
| 134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.15581260 |
| 135 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.15457783 |
| 136 | regulation of growth of symbiont in host (GO:0044126) | 2.15457783 |
| 137 | negative regulation of growth of symbiont in host (GO:0044130) | 2.15457783 |
| 138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.15457783 |
| 139 | germinal center formation (GO:0002467) | 2.15452711 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.14331873 |
| 141 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.13370907 |
| 142 | myeloid cell activation involved in immune response (GO:0002275) | 2.13353047 |
| 143 | regulation of histone H3-K27 methylation (GO:0061085) | 2.13215290 |
| 144 | T-helper 1 type immune response (GO:0042088) | 2.12583738 |
| 145 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.12178645 |
| 146 | early endosome to late endosome transport (GO:0045022) | 2.12177858 |
| 147 | histamine secretion (GO:0001821) | 2.11769702 |
| 148 | regulation of chemokine secretion (GO:0090196) | 2.11653874 |
| 149 | regulation of respiratory burst (GO:0060263) | 2.11558605 |
| 150 | defense response to fungus (GO:0050832) | 2.11275988 |
| 151 | positive regulation by host of viral transcription (GO:0043923) | 2.11203394 |
| 152 | regulation of T cell tolerance induction (GO:0002664) | 2.10804389 |
| 153 | response to lipoprotein particle (GO:0055094) | 2.09441724 |
| 154 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.09427895 |
| 155 | angiogenesis involved in wound healing (GO:0060055) | 2.08635757 |
| 156 | T cell selection (GO:0045058) | 2.08357794 |
| 157 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.08095061 |
| 158 | glandular epithelial cell development (GO:0002068) | 2.07984683 |
| 159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.07888711 |
| 160 | exocrine pancreas development (GO:0031017) | 2.07740848 |
| 161 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.07722108 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.07722108 |
| 163 | cellular response to fluid shear stress (GO:0071498) | 2.07695335 |
| 164 | cell wall macromolecule catabolic process (GO:0016998) | 2.07643474 |
| 165 | positive regulation of glycogen metabolic process (GO:0070875) | 2.07596094 |
| 166 | histone lysine demethylation (GO:0070076) | 2.06990566 |
| 167 | hyaluronan catabolic process (GO:0030214) | 2.06362480 |
| 168 | macrophage activation (GO:0042116) | 2.06059155 |
| 169 | regulation of glycolytic process (GO:0006110) | 2.05700977 |
| 170 | response to fluid shear stress (GO:0034405) | 2.05561139 |
| 171 | regulation of histone deacetylation (GO:0031063) | 2.05054270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.61290683 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.10273907 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.96967039 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.58953965 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.44264371 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.43237725 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19207727 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.06945910 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01867402 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.82465406 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80914127 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75560910 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.73664590 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70580825 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67578305 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65219809 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63827298 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.38641073 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30870435 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23922028 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22215735 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10559389 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08617339 |
| 24 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.05182447 |
| 25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04189255 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.02057142 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.94824973 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91365245 |
| 29 | * MYC_22102868_ChIP-Seq_BL_Human | 1.81716072 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79923581 |
| 31 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78413635 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74229392 |
| 33 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71066265 |
| 34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.63561776 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63015746 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61875293 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61174241 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61160759 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60884011 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60115818 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57700813 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56980284 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54229424 |
| 44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.53427268 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53122356 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52861357 |
| 47 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.50384594 |
| 48 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.46745947 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45633328 |
| 50 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45465370 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44757449 |
| 52 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42832679 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41714638 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41383279 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40933261 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40818023 |
| 57 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37851594 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37462029 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36924350 |
| 60 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35644010 |
| 61 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34906119 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32765280 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32572511 |
| 64 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.32159305 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30932623 |
| 66 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30658257 |
| 67 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28824826 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27710723 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27211018 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27061136 |
| 71 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26987520 |
| 72 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26608845 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26587234 |
| 74 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25875795 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24555348 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20064770 |
| 77 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19029100 |
| 78 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19029100 |
| 79 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18591376 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18277567 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18229509 |
| 82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18098834 |
| 83 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17797848 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17610955 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17315526 |
| 86 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16956788 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16431533 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14967681 |
| 89 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.14468813 |
| 90 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13183812 |
| 91 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.12413179 |
| 92 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.12045120 |
| 93 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11340820 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11170042 |
| 95 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11084771 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10922805 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10749302 |
| 98 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10265333 |
| 99 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09630954 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08937238 |
| 101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08515287 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07986102 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07877909 |
| 104 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07476972 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06474202 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05696302 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05312379 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04759987 |
| 109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04582320 |
| 110 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04563425 |
| 111 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03439936 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03345444 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03109654 |
| 114 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.02310684 |
| 115 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02263506 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02038947 |
| 117 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01166285 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99567423 |
| 119 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99100566 |
| 120 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98953801 |
| 121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96955903 |
| 122 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96359768 |
| 123 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96042894 |
| 124 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95951060 |
| 125 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95490752 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94240986 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94225160 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91714653 |
| 129 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91169113 |
| 130 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91098520 |
| 131 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91094604 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90028866 |
| 133 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.89902008 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88664645 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86558331 |
| 136 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.86150370 |
| 137 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.84748834 |
| 138 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84658156 |
| 139 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84425941 |
| 140 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84198630 |
| 141 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82810080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.61237878 |
| 2 | MP0003303_peritoneal_inflammation | 2.66521385 |
| 3 | MP0002166_altered_tumor_susceptibility | 2.56559456 |
| 4 | MP0008057_abnormal_DNA_replication | 2.46104876 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.35007228 |
| 6 | MP0003436_decreased_susceptibility_to | 2.33040325 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.18778023 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.07179156 |
| 9 | MP0003724_increased_susceptibility_to | 2.03428430 |
| 10 | MP0005076_abnormal_cell_differentiation | 1.99469237 |
| 11 | MP0002396_abnormal_hematopoietic_system | 1.98376722 |
| 12 | MP0001790_abnormal_immune_system | 1.91103524 |
| 13 | MP0005387_immune_system_phenotype | 1.91103524 |
| 14 | MP0005058_abnormal_lysosome_morphology | 1.89608556 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 1.87708878 |
| 16 | MP0006054_spinal_hemorrhage | 1.85152688 |
| 17 | MP0002419_abnormal_innate_immunity | 1.85119386 |
| 18 | MP0003943_abnormal_hepatobiliary_system | 1.83284508 |
| 19 | MP0003183_abnormal_peptide_metabolism | 1.82765154 |
| 20 | MP0002006_tumorigenesis | 1.81764472 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.81484793 |
| 22 | MP0001800_abnormal_humoral_immune | 1.74261549 |
| 23 | MP0002009_preneoplasia | 1.73650700 |
| 24 | MP0001851_eye_inflammation | 1.72917429 |
| 25 | MP0000685_abnormal_immune_system | 1.71203740 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.68947573 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.68812871 |
| 28 | MP0004947_skin_inflammation | 1.67046874 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.63306870 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.60670340 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.60433115 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.59787038 |
| 33 | MP0003828_pulmonary_edema | 1.57545090 |
| 34 | MP0002405_respiratory_system_inflammati | 1.57398312 |
| 35 | MP0002723_abnormal_immune_serum | 1.56241881 |
| 36 | MP0003045_fibrosis | 1.56201222 |
| 37 | MP0009278_abnormal_bone_marrow | 1.55138821 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.52948600 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.52732376 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.51495243 |
| 41 | MP0001819_abnormal_immune_cell | 1.50538336 |
| 42 | MP0003195_calcinosis | 1.50387122 |
| 43 | MP0005025_abnormal_response_to | 1.48137684 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.48042417 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.46613938 |
| 46 | MP0005671_abnormal_response_to | 1.45012454 |
| 47 | MP0002933_joint_inflammation | 1.43156917 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.42493491 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.41122268 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.38961645 |
| 51 | MP0002132_abnormal_respiratory_system | 1.38758303 |
| 52 | MP0003252_abnormal_bile_duct | 1.37854101 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.37738713 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.37570441 |
| 55 | MP0002060_abnormal_skin_morphology | 1.36792147 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.36582973 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.34843129 |
| 58 | MP0000516_abnormal_urinary_system | 1.34843129 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.31899719 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.30553692 |
| 61 | MP0001853_heart_inflammation | 1.30398842 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.29823811 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.26992650 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.26532590 |
| 65 | MP0002928_abnormal_bile_duct | 1.23358299 |
| 66 | MP0001873_stomach_inflammation | 1.22884202 |
| 67 | MP0002398_abnormal_bone_marrow | 1.20454684 |
| 68 | MP0004510_myositis | 1.19782333 |
| 69 | MP0003866_abnormal_defecation | 1.19684991 |
| 70 | MP0000716_abnormal_immune_system | 1.19590714 |
| 71 | MP0005275_abnormal_skin_tensile | 1.18820500 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.18809828 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.18809828 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 1.17191940 |
| 75 | MP0004381_abnormal_hair_follicle | 1.14905361 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.12561252 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.12416708 |
| 78 | MP0000569_abnormal_digit_pigmentation | 1.10787810 |
| 79 | MP0004484_altered_response_of | 1.08925031 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.08718409 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 1.08149063 |
| 82 | MP0002693_abnormal_pancreas_physiology | 1.08110525 |
| 83 | MP0009785_altered_susceptibility_to | 1.07474205 |
| 84 | MP0005670_abnormal_white_adipose | 1.06119315 |
| 85 | MP0003795_abnormal_bone_structure | 1.05904674 |
| 86 | MP0001756_abnormal_urination | 1.05598307 |
| 87 | MP0005390_skeleton_phenotype | 1.05523567 |
| 88 | MP0005023_abnormal_wound_healing | 1.05441506 |
| 89 | MP0009115_abnormal_fat_cell | 1.04367400 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.03405945 |
| 91 | MP0000343_altered_response_to | 1.01610636 |
| 92 | MP0010678_abnormal_skin_adnexa | 1.00744487 |
| 93 | MP0001270_distended_abdomen | 1.00348292 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.99757873 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.99722637 |
| 96 | MP0002722_abnormal_immune_system | 0.98541267 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.98311534 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.97519798 |
| 99 | MP0003279_aneurysm | 0.96623059 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.96441677 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.96397758 |
| 102 | MP0005365_abnormal_bile_salt | 0.96384382 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.96009727 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.95144600 |
| 105 | MP0000858_altered_metastatic_potential | 0.94172945 |
| 106 | MP0000383_abnormal_hair_follicle | 0.93719247 |
| 107 | MP0003448_altered_tumor_morphology | 0.93533251 |
| 108 | MP0002429_abnormal_blood_cell | 0.93299895 |
| 109 | MP0010307_abnormal_tumor_latency | 0.92843615 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.92440398 |
| 111 | MP0000490_abnormal_crypts_of | 0.91934015 |
| 112 | MP0000609_abnormal_liver_physiology | 0.91494263 |
| 113 | MP0005310_abnormal_salivary_gland | 0.91167466 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.90602673 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.88737234 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.88417320 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.86554041 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.86218263 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.86127628 |
| 120 | MP0009931_abnormal_skin_appearance | 0.85962047 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.85721286 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.84783959 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.84171687 |
| 124 | MP0001958_emphysema | 0.82769311 |
| 125 | MP0002078_abnormal_glucose_homeostasis | 0.81964972 |
| 126 | MP0008995_early_reproductive_senescence | 0.81885675 |
| 127 | MP0000377_abnormal_hair_follicle | 0.81457825 |
| 128 | MP0002971_abnormal_brown_adipose | 0.81260308 |
| 129 | MP0008469_abnormal_protein_level | 0.80362134 |
| 130 | MP0002098_abnormal_vibrissa_morphology | 0.79772402 |
| 131 | MP0001764_abnormal_homeostasis | 0.79164176 |
| 132 | MP0000598_abnormal_liver_morphology | 0.78848321 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.78833944 |
| 134 | MP0001243_abnormal_dermal_layer | 0.78414466 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.78367766 |
| 136 | MP0002168_other_aberrant_phenotype | 0.78186060 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.77934264 |
| 138 | MP0002163_abnormal_gland_morphology | 0.77051296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.21211221 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.75491402 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.74564967 |
| 4 | Large for gestational age (HP:0001520) | 3.18213903 |
| 5 | Hematochezia (HP:0002573) | 3.11022986 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.04595404 |
| 7 | Testicular neoplasm (HP:0010788) | 3.01694604 |
| 8 | Abnormal sex determination (HP:0012244) | 2.99522985 |
| 9 | Sex reversal (HP:0012245) | 2.99522985 |
| 10 | Widely spaced teeth (HP:0000687) | 2.98209844 |
| 11 | Cerebral aneurysm (HP:0004944) | 2.91173354 |
| 12 | Abnormality of the fingertips (HP:0001211) | 2.86925523 |
| 13 | Periodontitis (HP:0000704) | 2.85289759 |
| 14 | Mucopolysacchariduria (HP:0008155) | 2.83717937 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.83717937 |
| 16 | Recurrent fungal infections (HP:0002841) | 2.83217886 |
| 17 | Spondylolisthesis (HP:0003302) | 2.79108680 |
| 18 | Acute lymphatic leukemia (HP:0006721) | 2.73118731 |
| 19 | Hyperglycemia (HP:0003074) | 2.72299162 |
| 20 | Hypothermia (HP:0002045) | 2.69422927 |
| 21 | Hamartoma of the eye (HP:0010568) | 2.65060448 |
| 22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65049458 |
| 23 | Osteolytic defects of the hand bones (HP:0009699) | 2.65049458 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60813321 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60813321 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60813321 |
| 27 | Macroorchidism (HP:0000053) | 2.60258800 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.58520839 |
| 29 | Germ cell neoplasia (HP:0100728) | 2.55371033 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.55036398 |
| 31 | Cellulitis (HP:0100658) | 2.51238901 |
| 32 | Recurrent skin infections (HP:0001581) | 2.50313342 |
| 33 | Ketoacidosis (HP:0001993) | 2.48962070 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.47958599 |
| 35 | Increased CSF protein (HP:0002922) | 2.47891568 |
| 36 | Inflammation of the large intestine (HP:0002037) | 2.47218929 |
| 37 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44724099 |
| 38 | Gingivitis (HP:0000230) | 2.44222810 |
| 39 | Exocrine pancreatic insufficiency (HP:0001738) | 2.42047115 |
| 40 | Metaphyseal dysplasia (HP:0100255) | 2.40718115 |
| 41 | Lip pit (HP:0100267) | 2.40432181 |
| 42 | IgM deficiency (HP:0002850) | 2.38303248 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37708125 |
| 44 | Recurrent viral infections (HP:0004429) | 2.36181676 |
| 45 | Fair hair (HP:0002286) | 2.35789772 |
| 46 | Myocardial infarction (HP:0001658) | 2.34874202 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.33437440 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.33437440 |
| 49 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.32551945 |
| 50 | Malnutrition (HP:0004395) | 2.32088955 |
| 51 | Aortic aneurysm (HP:0004942) | 2.31786957 |
| 52 | Febrile seizures (HP:0002373) | 2.30360817 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.27095280 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.25203739 |
| 55 | Hyperkalemia (HP:0002153) | 2.24167996 |
| 56 | Abnormality of the nasal septum (HP:0000419) | 2.23522912 |
| 57 | Enlarged penis (HP:0000040) | 2.21257712 |
| 58 | Symptomatic seizures (HP:0011145) | 2.21056333 |
| 59 | Chronic otitis media (HP:0000389) | 2.19693251 |
| 60 | Conjunctival hamartoma (HP:0100780) | 2.19670643 |
| 61 | Myositis (HP:0100614) | 2.19243125 |
| 62 | Colitis (HP:0002583) | 2.19124345 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.17731948 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.17350767 |
| 65 | Hypochromic anemia (HP:0001931) | 2.16832479 |
| 66 | Generalized hypopigmentation of hair (HP:0011358) | 2.16415201 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.16344199 |
| 68 | Amyloidosis (HP:0011034) | 2.14817953 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14427005 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14427005 |
| 71 | Spinal cord lesions (HP:0100561) | 2.14163076 |
| 72 | Syringomyelia (HP:0003396) | 2.14163076 |
| 73 | Increased IgE level (HP:0003212) | 2.13829985 |
| 74 | Gingival bleeding (HP:0000225) | 2.13257590 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.11966357 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11686998 |
| 77 | Osteomyelitis (HP:0002754) | 2.10026032 |
| 78 | Mitral valve prolapse (HP:0001634) | 2.09774617 |
| 79 | Meningitis (HP:0001287) | 2.06894980 |
| 80 | Curly hair (HP:0002212) | 2.04654490 |
| 81 | Stomach cancer (HP:0012126) | 2.04410155 |
| 82 | Milia (HP:0001056) | 2.04018429 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.02180081 |
| 84 | Atrophic scars (HP:0001075) | 2.00064880 |
| 85 | Arterial thrombosis (HP:0004420) | 1.99291124 |
| 86 | Pustule (HP:0200039) | 1.99194803 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99031292 |
| 88 | Obstructive lung disease (HP:0006536) | 1.99031292 |
| 89 | Disinhibition (HP:0000734) | 1.98771431 |
| 90 | Thin bony cortex (HP:0002753) | 1.98676970 |
| 91 | Persistence of primary teeth (HP:0006335) | 1.96741681 |
| 92 | Acute myeloid leukemia (HP:0004808) | 1.95722091 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.91781540 |
| 94 | Aortic dissection (HP:0002647) | 1.91313775 |
| 95 | Viral hepatitis (HP:0006562) | 1.90206280 |
| 96 | Abnormal platelet function (HP:0011869) | 1.89706951 |
| 97 | Impaired platelet aggregation (HP:0003540) | 1.89706951 |
| 98 | Hemoptysis (HP:0002105) | 1.89662046 |
| 99 | Thick nail (HP:0001805) | 1.89448134 |
| 100 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88810927 |
| 101 | Neoplasm of the adrenal cortex (HP:0100641) | 1.87019237 |
| 102 | Cervical subluxation (HP:0003308) | 1.85660101 |
| 103 | Pulmonary infiltrates (HP:0002113) | 1.85488637 |
| 104 | Abnormality of the axillary hair (HP:0100134) | 1.85285483 |
| 105 | Abnormality of secondary sexual hair (HP:0009888) | 1.85285483 |
| 106 | Septate vagina (HP:0001153) | 1.84593056 |
| 107 | Menstrual irregularities (HP:0000858) | 1.84437549 |
| 108 | Narrow palate (HP:0000189) | 1.83882147 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 1.83479621 |
| 110 | Submucous cleft hard palate (HP:0000176) | 1.83187308 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 1.83148995 |
| 112 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83112049 |
| 113 | Alopecia of scalp (HP:0002293) | 1.82823975 |
| 114 | Asymmetry of the thorax (HP:0001555) | 1.82358107 |
| 115 | Tubulointerstitial nephritis (HP:0001970) | 1.82051688 |
| 116 | Epistaxis (HP:0000421) | 1.81025715 |
| 117 | Stomatitis (HP:0010280) | 1.80519446 |
| 118 | Abnormality of the renal cortex (HP:0011035) | 1.79882431 |
| 119 | Gonadal dysgenesis (HP:0000133) | 1.79367042 |
| 120 | Ketosis (HP:0001946) | 1.78462710 |
| 121 | Neoplasm of the lung (HP:0100526) | 1.77809604 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.77312066 |
| 123 | Vasculitis (HP:0002633) | 1.77064794 |
| 124 | Sepsis (HP:0100806) | 1.77032331 |
| 125 | Coarse hair (HP:0002208) | 1.77028443 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.76997846 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.76186010 |
| 128 | T lymphocytopenia (HP:0005403) | 1.76166152 |
| 129 | Hamartoma (HP:0010566) | 1.75325403 |
| 130 | Pigmentary retinal degeneration (HP:0001146) | 1.74858034 |
| 131 | Cheilitis (HP:0100825) | 1.74550176 |
| 132 | Broad face (HP:0000283) | 1.73924300 |
| 133 | Absent frontal sinuses (HP:0002688) | 1.73918484 |
| 134 | Increased density of long bones (HP:0006392) | 1.73018214 |
| 135 | Episodic fever (HP:0001954) | 1.72929098 |
| 136 | Chronic diarrhea (HP:0002028) | 1.72519537 |
| 137 | Thyroiditis (HP:0100646) | 1.72128784 |
| 138 | Visceral angiomatosis (HP:0100761) | 1.71761477 |
| 139 | Decreased circulating renin level (HP:0003351) | 1.71645001 |
| 140 | Arterial tortuosity (HP:0005116) | 1.71621383 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.70816049 |
| 142 | Hypokalemic alkalosis (HP:0001949) | 1.70779552 |
| 143 | Craniofacial hyperostosis (HP:0004493) | 1.70475350 |
| 144 | Shallow orbits (HP:0000586) | 1.70289736 |
| 145 | Glomerulonephritis (HP:0000099) | 1.70266527 |
| 146 | Fragile skin (HP:0001030) | 1.69590635 |
| 147 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69561922 |
| 148 | Eosinophilia (HP:0001880) | 1.69415381 |
| 149 | Thickened calvaria (HP:0002684) | 1.68532818 |
| 150 | Bone pain (HP:0002653) | 1.68069333 |
| 151 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.67401129 |
| 152 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67357303 |
| 153 | Gastrointestinal infarctions (HP:0005244) | 1.66636274 |
| 154 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66623341 |
| 155 | Villous atrophy (HP:0011473) | 1.64985124 |
| 156 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.64985124 |
| 157 | Mitral stenosis (HP:0001718) | 1.64973071 |
| 158 | Generalized hyperpigmentation (HP:0007440) | 1.64761078 |
| 159 | Orchitis (HP:0100796) | 1.64125542 |
| 160 | Thrombocytosis (HP:0001894) | 1.62734925 |
| 161 | Abnormality of the frontal sinuses (HP:0002687) | 1.60857246 |
| 162 | Peritonitis (HP:0002586) | 1.60733592 |
| 163 | Chest pain (HP:0100749) | 1.60507078 |
| 164 | Hypoglycemic seizures (HP:0002173) | 1.60139719 |
| 165 | Abnormal platelet volume (HP:0011876) | 1.59418662 |
| 166 | Urethral obstruction (HP:0000796) | 1.59286297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 2.55908813 |
| 2 | TGFBR2 | 2.50734791 |
| 3 | MAP4K1 | 2.45154785 |
| 4 | EPHB1 | 2.32219362 |
| 5 | MAPK15 | 2.27773957 |
| 6 | AKT3 | 2.23718205 |
| 7 | MAP3K10 | 2.22580569 |
| 8 | TRIB3 | 2.02639482 |
| 9 | FRK | 1.99646118 |
| 10 | IRAK4 | 1.92464134 |
| 11 | ERN1 | 1.92188877 |
| 12 | INSRR | 1.88386382 |
| 13 | HIPK2 | 1.79247654 |
| 14 | PRPF4B | 1.77647437 |
| 15 | DMPK | 1.73801370 |
| 16 | STK10 | 1.73210022 |
| 17 | IRAK3 | 1.69841572 |
| 18 | ITK | 1.69811301 |
| 19 | FLT3 | 1.62163589 |
| 20 | TEC | 1.61239589 |
| 21 | JAK1 | 1.57895496 |
| 22 | CAMK1D | 1.57225881 |
| 23 | TYK2 | 1.57222267 |
| 24 | FGFR3 | 1.56428681 |
| 25 | BRSK2 | 1.55988336 |
| 26 | SIK1 | 1.54363885 |
| 27 | PTK6 | 1.52207453 |
| 28 | PKN2 | 1.52204595 |
| 29 | EPHA3 | 1.48480308 |
| 30 | MAP3K14 | 1.46804152 |
| 31 | EEF2K | 1.46769676 |
| 32 | KIT | 1.44053979 |
| 33 | RIPK1 | 1.41707138 |
| 34 | FER | 1.40634879 |
| 35 | JAK3 | 1.39881512 |
| 36 | BRD4 | 1.36020640 |
| 37 | ZAP70 | 1.35430313 |
| 38 | CAMK1G | 1.31646912 |
| 39 | CHUK | 1.31117442 |
| 40 | BTK | 1.29770122 |
| 41 | CDK6 | 1.29679870 |
| 42 | CSF1R | 1.25463481 |
| 43 | SGK2 | 1.24023700 |
| 44 | YES1 | 1.23556237 |
| 45 | FGFR4 | 1.21430943 |
| 46 | TBK1 | 1.20483120 |
| 47 | LRRK2 | 1.19398502 |
| 48 | TRPM7 | 1.16515659 |
| 49 | FGFR2 | 1.15693399 |
| 50 | CDK12 | 1.15060778 |
| 51 | TXK | 1.14869727 |
| 52 | IKBKB | 1.14670745 |
| 53 | CSK | 1.13723081 |
| 54 | IRAK2 | 1.12844848 |
| 55 | MAP3K13 | 1.10588083 |
| 56 | IKBKE | 1.10148354 |
| 57 | BMPR2 | 1.06659456 |
| 58 | MAP2K2 | 1.02775094 |
| 59 | MAP3K7 | 1.01012381 |
| 60 | PIM1 | 1.00325251 |
| 61 | LATS1 | 1.00308930 |
| 62 | NEK9 | 0.99375674 |
| 63 | TNK2 | 0.96638585 |
| 64 | PDGFRB | 0.96592802 |
| 65 | TTN | 0.95328384 |
| 66 | NLK | 0.93942783 |
| 67 | SMG1 | 0.93242284 |
| 68 | MAPK7 | 0.93241662 |
| 69 | PASK | 0.93036184 |
| 70 | NUAK1 | 0.92470519 |
| 71 | HCK | 0.91302348 |
| 72 | MAP2K3 | 0.89662121 |
| 73 | MAPKAPK3 | 0.87947524 |
| 74 | BLK | 0.87632745 |
| 75 | CLK1 | 0.86498649 |
| 76 | JAK2 | 0.85652897 |
| 77 | GRK6 | 0.84549735 |
| 78 | MAP2K6 | 0.84281675 |
| 79 | STK3 | 0.84258323 |
| 80 | RPS6KB2 | 0.83864706 |
| 81 | LCK | 0.83582049 |
| 82 | SIK3 | 0.83522154 |
| 83 | DYRK1B | 0.82524793 |
| 84 | RPS6KA4 | 0.82145814 |
| 85 | CDK9 | 0.81040119 |
| 86 | PDGFRA | 0.77958626 |
| 87 | CDK3 | 0.74824595 |
| 88 | MAPK11 | 0.73972938 |
| 89 | EIF2AK3 | 0.72538215 |
| 90 | SYK | 0.70287500 |
| 91 | MAPK12 | 0.69905426 |
| 92 | RPS6KA6 | 0.69648425 |
| 93 | DAPK2 | 0.68689191 |
| 94 | GSK3A | 0.68631117 |
| 95 | MAPKAPK2 | 0.67789443 |
| 96 | TAOK1 | 0.67554030 |
| 97 | IRAK1 | 0.67374672 |
| 98 | RPS6KL1 | 0.66976995 |
| 99 | RPS6KC1 | 0.66976995 |
| 100 | MKNK2 | 0.66800403 |
| 101 | MARK3 | 0.65465445 |
| 102 | STK24 | 0.65230830 |
| 103 | PNCK | 0.64678379 |
| 104 | PRKD1 | 0.63407239 |
| 105 | SGK223 | 0.63155825 |
| 106 | SGK494 | 0.63155825 |
| 107 | SGK3 | 0.62089774 |
| 108 | MST4 | 0.60006649 |
| 109 | MAP3K3 | 0.59945238 |
| 110 | PINK1 | 0.58230923 |
| 111 | WEE1 | 0.58164592 |
| 112 | RIPK4 | 0.57760647 |
| 113 | MAPKAPK5 | 0.57382662 |
| 114 | RPS6KA5 | 0.57298570 |
| 115 | MAP3K2 | 0.56555549 |
| 116 | PDK1 | 0.56185609 |
| 117 | LYN | 0.56110960 |
| 118 | SCYL2 | 0.53742374 |
| 119 | MELK | 0.53623378 |
| 120 | PIM2 | 0.52890337 |
| 121 | ERBB3 | 0.52470485 |
| 122 | PIK3CG | 0.52222549 |
| 123 | MTOR | 0.51917167 |
| 124 | SIK2 | 0.51128774 |
| 125 | RPS6KB1 | 0.50472738 |
| 126 | PRKD2 | 0.50210049 |
| 127 | MAP4K2 | 0.49988217 |
| 128 | CAMK4 | 0.48745678 |
| 129 | MAPK4 | 0.48630443 |
| 130 | PAK4 | 0.48248381 |
| 131 | PAK2 | 0.48156454 |
| 132 | STK4 | 0.48147063 |
| 133 | RPS6KA2 | 0.47485668 |
| 134 | FES | 0.46501383 |
| 135 | PRKAA2 | 0.46203957 |
| 136 | GRK1 | 0.44084379 |
| 137 | PRKCQ | 0.43956408 |
| 138 | PIK3CA | 0.43832318 |
| 139 | MAP3K1 | 0.42985459 |
| 140 | STK39 | 0.41696865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.32514067 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29257315 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.21959093 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09013669 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95980796 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92685770 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76705780 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75768479 |
| 9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70767407 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64693404 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62312406 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61572409 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.58339276 |
| 14 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.53926952 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50514542 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48021584 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46913561 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45770664 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.42949397 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41873389 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41699705 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39654300 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.39317211 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.39094407 |
| 25 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.38840124 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34190886 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.33335288 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30656592 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.29947044 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.29386052 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.28948372 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24468410 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22986837 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22771705 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22769797 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22185684 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.21205585 |
| 38 | Prostate cancer_Homo sapiens_hsa05215 | 1.20445515 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19819400 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.15552832 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14723139 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13105072 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.12286942 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.11421523 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.07565081 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.06554232 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05549898 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04555458 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 1.03869430 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03839170 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 1.03794134 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.03252233 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.01875962 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01673063 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00960362 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99890375 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.99793706 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99788948 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99541449 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.98767847 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98338231 |
| 62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97403967 |
| 63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97389090 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.95949946 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94972514 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94779674 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94397700 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93480931 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93152920 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92029464 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91396693 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90933094 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90741938 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89596273 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.87847688 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86335905 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84476244 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81485997 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81216692 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81078903 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80678201 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80242016 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80213760 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79994011 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79309489 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.79158316 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77653937 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77346405 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.76599185 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74354293 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.72020001 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71721582 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71159666 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71109969 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70115265 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.69280311 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.69083460 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68393463 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66629378 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66188747 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66180332 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66077623 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65723846 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65189452 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64781415 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64065913 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63838843 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63030357 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62877036 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62050740 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61982415 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.61838162 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61484830 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61390742 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60610803 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60101982 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59879736 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59657010 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59497328 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57951340 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57825921 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.57117693 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56796417 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56007559 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55651513 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54478943 |
| 127 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54246047 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53879063 |
| 129 | Salivary secretion_Homo sapiens_hsa04970 | 0.52538046 |
| 130 | Long-term depression_Homo sapiens_hsa04730 | 0.52414446 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50611615 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49711782 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.49646048 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48541617 |
| 135 | Protein export_Homo sapiens_hsa03060 | 0.48523495 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47029536 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.46568140 |
| 138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46216009 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45600278 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43656285 |

